文献速递其他结缔组织病

控制系统性硬化症指端溃疡与手功能改善相关

Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function.
PubMed 文献 · Semin Arthritis Rheum · 2017-01-13

ECLIPSE 研究纳入 190 例既往一年内至少发生 1 次指端溃疡(DU)并接受波生坦治疗的系统性硬化症(SSc)患者,随访 1 年时 120 例有数据。38.3% 患者出现新发 DU,总体 DU 数、残疾评分、疼痛评分均改善,改善主要归于溃疡控制者。

要点

  • 控制溃疡病活动 1 年与手部残疾显著减轻相关。
  • 随访期间 38.3% 患者仍出现新发 DU 事件。
  • 溃疡控制者 HAQ-DI、CHFS 和疼痛评分均显著改善。

核心结论

  • 在 SSc 患者中,控制溃疡病活动 1 年与手部残疾显著减轻相关。

研究设计与样本

  • ECLIPSE(研究 AC-052-517)为为期 2 年的前瞻性、多中心、观察性研究。
  • 主要终点为入组时与 1 年后的残疾评分(CHFS、HAQ-DI)、疼痛评分(视觉模拟量表)和生活质量评分(SF-36)。
  • 溃疡病控制定义为入组至 1 年随访期间无持续或新发 DU 事件。

主要发现

  • 随访期间 46 例(38.3%)患者出现新发 DU 事件。
  • 每例患者 DU 数从入组时 1.4 ± 1.8 降至 1 年时 0.6 ± 1.6(p < 0.0001)。
  • HAQ-DI 从 1.0 ± 0.7 降至 0.9 ± 0.7(p = 0.04),CHFS 从 29 ± 20 降至 25 ± 20(p = 0.005)。
  • 疼痛评分从 4.3 ± 3.1 降至 2.9 ± 2.8(p < 0.0001)。
  • 改善归于溃疡病控制患者(48.3%),其 HAQ-DI(p = 0.04)、CHFS(p = 0.04)和疼痛评分(p = 0.046)显著改善。

关键数值与推荐

  • 溃疡病控制定义为入组至 1 年随访期间无持续或新发 DU 事件。
  • DU 数从 1.4 ± 1.8 降至 0.6 ± 1.6(p < 0.0001)。
  • HAQ-DI 从 1.0 ± 0.7 降至 0.9 ± 0.7(p = 0.04)。
  • CHFS 从 29 ± 20 降至 25 ± 20(p = 0.005)。
  • 疼痛评分从 4.3 ± 3.1 降至 2.9 ± 2.8(p < 0.0001)。

临床怎么用

  • 在 SSc 患者中,控制指端溃疡病活动可能有助于减轻手部残疾和疼痛。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Ischemic digital ulcers (DU) represent a major complication of systemic sclerosis (SSc). We investigated the impact of controlling the ulcerative disease on disability, pain, and quality of life in SSc patients receiving bosentan. METHODS: ECLIPSE (Study AC-052-517) is a 2-year prospective, multicenter, and observational study. Patients with SSc who experienced at least 1 DU in the previous year and received bosentan were included between October 2009 and March 2011. Disability scores [Cochin Hand Function Scale (CHFS) and Health Assessment Questionnaire Disability Index (HAQ-DI)], pain scores (visual analog scale), and quality-of-life scores (SF-36) were collected at inclusion and 1 year later (primary endpoint). A controlled ulcerative disease was defined by the absence of ongoing/new DU episode between inclusion and 1-year follow-up. RESULTS: Data were available at 1 year for 120 patients out of 190 included. During follow-up, 46 (38.3%) patients experienced a new DU episode. The number of DU per patient decreased from 1.4 ± 1.8 at inclusion to 0.6 ± 1.6 (p < 0.0001) at 1 year. Disability scores decreased from 1.0 ± 0.7 to 0.9 ± 0.7 (p = 0.04) for the HAQ-DI and from 29 ± 20 to 25 ± 20 (p = 0.005) for the CHFS; the pain score decreased from 4.3 ± 3.1 to 2.9 ± 2.8 (p < 0.0001). This improvement was attributed to patients with a controlled ulcerative disease (48.3%), who significantly improved HAQ-DI (p = 0.04), CHFS (p = 0.04), and pain score (p = 0.046). CONCLUSIONS: In patients with SSc, control of the ulcerative disease for 1 year was associated with significant attenuation of hand disability.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Mouthon L, Carpentier PH, Lok C, et al. Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. Semin Arthritis Rheum. 2017. PMID: 28214014. doi:10.1016/j.semarthrit.2017.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。